PAM
LFCR icon

Paradigm Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Paradigm Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,600
Closed -$17.2K – 721
2016
Q2 		$17.2K Hold
1,600
– – ﹤0.01% 733
2016
Q1 		$16.8K Sell
1,600
-3,150
-66% -$34.6K ﹤0.01% 762
2015
Q4 		$56.2K Buy
4,750
+150
+3% +$1.84K 0.01% 636
2015
Q3 		$53.7K Sell
4,600
-12,900
-74% -$171K 0.01% 618
2015
Q2 		$253K Hold
17,500
– – 0.03% 446
2015
Q1 		$244K Hold
17,500
– – 0.03% 446
2014
Q4 		$242K Hold
17,500
– – 0.03% 446
2014
Q3 		$214K Sell
17,500
-2,400
-12% -$30K 0.03% 453
2014
Q2 		$249K Buy
19,900
+500
+3% +$5.88K 0.03% 469
2014
Q1 		$217K Hold
19,400
– – 0.03% 481
2013
Q4 		$235K Hold
19,400
– – 0.04% 473
2013
Q3 		$237K Buy
19,400
+8,400
+76% +$117K 0.04% 461
2013
Q2 		$145K Buy
+11,000
New +$152K 0.02% 503

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Paradigm Asset Management's LFCR Position: Q3 2016 in Review

Paradigm Asset Management sold out of Lifecore Biomedical (LFCR) in Q3 2016, closing a stake of 1,600 shares — an estimated $17.2K sold.

Paradigm Asset Management first reported a position in LFCR in Q2 2013 and held it in 13 quarters. The position peaked at $253K in Q2 2015. 93 funds tracked by Wall St. Rank hold LFCR as of Q3 2016.

  • Paradigm Asset Management reported no remaining Lifecore Biomedical position as of Q3 2016 after selling out during the quarter.
  • Paradigm Asset Management sold 1,600 Lifecore Biomedical shares in Q3 2016, an estimated $17.2K.
  • Paradigm Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 13 quarters.
  • Paradigm Asset Management's Lifecore Biomedical position peaked at $253K in Q2 2015.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2016.

Based on Paradigm Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.